Alle randomiserede placebo- kontrollerede forsøg (inklusive andre indikationer end major depression), er blevet vurderet mht. bivirkninger ved Remeron.
All randomized placebo-controlled trials in patients (including indications other than major depressive disorder), have been evaluated for adverse reactions of Remeron.